Dyne Therapeutics, Inc. (DYN)
USD 7.48
(-9.66%)
USD 7.48
(-9.66%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -242.16 Million USD | -41.65% |
| 2022 | -170.96 Million USD | -13.96% |
| 2021 | -150.02 Million USD | -155.81% |
| 2020 | -58.64 Million USD | -324.18% |
| 2019 | -13.82 Million USD | -188.34% |
| 2018 | -4.79 Million USD | 98.84% |
| 2017 | -412 Million USD | 35.63% |
| 2016 | -640 Million USD | -1100.0% |
| 2015 | 64 Million USD | 120.13% |
| 2014 | -318 Million USD | 0.0% |
| 2013 | -318 Million USD | -144.54% |
| 2012 | 714 Million USD | 402.54% |
| 2011 | -236 Million USD | -2045.45% |
| 2010 | -11 Million USD | 98.68% |
| 2009 | -834 Million USD | -217.63% |
| 2008 | 709 Million USD | 17.19% |
| 2007 | 605 Million USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | -69.15 Million USD | -2.17% |
| 2024 Q2 | -71.96 Million USD | -4.06% |
| 2023 Q3 | -62.27 Million USD | 6.69% |
| 2023 Q2 | -66.73 Million USD | -46.79% |
| 2023 FY | -242.16 Million USD | -41.65% |
| 2023 Q1 | -45.46 Million USD | -13.25% |
| 2023 Q4 | -67.68 Million USD | -8.7% |
| 2022 Q3 | -42.27 Million USD | 19.86% |
| 2022 FY | -170.96 Million USD | -13.96% |
| 2022 Q4 | -40.14 Million USD | 5.05% |
| 2022 Q1 | -35.78 Million USD | 31.13% |
| 2022 Q2 | -52.75 Million USD | -47.43% |
| 2021 Q3 | -42.76 Million USD | -41.77% |
| 2021 FY | -150.02 Million USD | -155.81% |
| 2021 Q4 | -51.96 Million USD | -21.5% |
| 2021 Q2 | -30.16 Million USD | -20.02% |
| 2021 Q1 | -25.13 Million USD | 12.12% |
| 2020 Q2 | -8.67 Million USD | -10.47% |
| 2020 Q1 | -7.85 Million USD | -43.56% |
| 2020 Q3 | -13.52 Million USD | -55.85% |
| 2020 FY | -58.64 Million USD | -324.18% |
| 2020 Q4 | -28.6 Million USD | -111.54% |
| 2019 Q3 | -3.62 Million USD | -53.58% |
| 2019 Q1 | -2.36 Million USD | 0.0% |
| 2019 FY | -13.82 Million USD | -188.34% |
| 2019 Q4 | -5.47 Million USD | -50.73% |
| 2019 Q2 | -2.36 Million USD | 0.0% |
| 2018 FY | -4.79 Million USD | 98.84% |
| 2017 FY | -412 Million USD | 35.63% |
| 2017 Q4 | -467 Million USD | -905.17% |
| 2017 Q3 | 58 Million USD | 190.0% |
| 2017 Q2 | 20 Million USD | 140.82% |
| 2017 Q1 | -49 Million USD | -244.12% |
| 2016 Q1 | 145 Million USD | 1215.38% |
| 2016 Q2 | -552 Million USD | -480.69% |
| 2016 Q3 | -117 Million USD | 78.8% |
| 2016 Q4 | 34 Million USD | 129.06% |
| 2016 FY | -640 Million USD | -1100.0% |
| 2015 FY | 64 Million USD | 120.13% |
| 2015 Q4 | -13 Million USD | -112.15% |
| 2015 Q3 | 107 Million USD | 970.0% |
| 2015 Q2 | 10 Million USD | 1100.0% |
| 2015 Q1 | -1 Million USD | -103.23% |
| 2014 Q1 | 1 Million USD | 100.93% |
| 2014 Q4 | 31 Million USD | 40.91% |
| 2014 Q3 | 22 Million USD | 113.75% |
| 2014 Q2 | -160 Million USD | -16100.0% |
| 2014 FY | -318 Million USD | 0.0% |
| 2013 Q3 | 15 Million USD | 113.51% |
| 2013 Q4 | -107 Million USD | -813.33% |
| 2013 FY | -318 Million USD | -144.54% |
| 2013 Q1 | -115 Million USD | -115.52% |
| 2013 Q2 | -111 Million USD | 3.48% |
| 2012 Q4 | 741 Million USD | -28.06% |
| 2012 Q3 | 1.03 Billion USD | 203.1% |
| 2012 FY | 714 Million USD | 402.54% |
| 2012 Q2 | -999 Million USD | -1622.41% |
| 2012 Q1 | -58 Million USD | 96.12% |
| 2011 Q3 | 5 Million USD | 104.72% |
| 2011 Q1 | -49 Million USD | 69.94% |
| 2011 Q2 | -106 Million USD | -116.33% |
| 2011 Q4 | -1.49 Billion USD | -30000.0% |
| 2011 FY | -236 Million USD | -2045.45% |
| 2010 Q1 | 331 Million USD | 257.62% |
| 2010 Q4 | -163 Million USD | -426.0% |
| 2010 FY | -11 Million USD | 98.68% |
| 2010 Q3 | 50 Million USD | -50.89% |
| 2010 Q2 | 101.8 Million USD | -69.24% |
| 2009 Q1 | 200 Million USD | 86.92% |
| 2009 Q4 | -210 Million USD | -418.18% |
| 2009 FY | -834 Million USD | -217.63% |
| 2009 Q3 | 66 Million USD | 107.42% |
| 2009 Q2 | -890 Million USD | -545.0% |
| 2008 Q4 | 107 Million USD | -90.41% |
| 2008 FY | 709 Million USD | 17.19% |
| 2008 Q1 | -150 Million USD | -257.89% |
| 2008 Q2 | -364 Million USD | -142.67% |
| 2008 Q3 | 1.11 Billion USD | 406.59% |
| 2007 Q3 | 247 Million USD | 33.51% |
| 2007 FY | 605 Million USD | 0.0% |
| 2007 Q4 | 95 Million USD | -61.54% |
| 2007 Q2 | 185 Million USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| AbCellera Biologics Inc. | -237.2 Million USD | -2.089% |
| Alkermes plc | 414.12 Million USD | 158.476% |
| Agenus Inc. | -159.54 Million USD | -51.779% |
| Aptorum Group Limited | -10.52 Million USD | -2201.192% |
| Ardelyx, Inc. | -63.27 Million USD | -282.708% |
| Dyadic International, Inc. | -8.22 Million USD | -2842.523% |
| Eton Pharmaceuticals, Inc. | -1.19 Million USD | -20215.604% |
| Lantern Pharma Inc. | -17.87 Million USD | -1254.558% |
| Inhibikase Therapeutics, Inc. | -20.08 Million USD | -1105.398% |
| Novavax, Inc. | -566.51 Million USD | 57.254% |
| Janux Therapeutics, Inc. | -72.97 Million USD | -231.824% |
| Pyxis Oncology, Inc. | -82.19 Million USD | -194.615% |
| TransCode Therapeutics, Inc. | -19.41 Million USD | -1147.067% |
| Ocuphire Pharma, Inc. | -10.56 Million USD | -2192.549% |
| Outlook Therapeutics, Inc. | -53.12 Million USD | -355.822% |
| Madrigal Pharmaceuticals, Inc. | -380.49 Million USD | 36.356% |
| Reviva Pharmaceuticals Holdings, Inc. | -24.3 Million USD | -896.281% |
| SELLAS Life Sciences Group, Inc. | -37.86 Million USD | -539.473% |
| Syros Pharmaceuticals, Inc. | -128.98 Million USD | -87.74% |
| Barinthus Biotherapeutics plc | -83.91 Million USD | -188.584% |
| Windtree Therapeutics, Inc. | -17.53 Million USD | -1280.706% |
| Xeris Biopharma Holdings, Inc. | -44.01 Million USD | -450.243% |
| Clearside Biomedical, Inc. | -24.84 Million USD | -874.73% |
| C4 Therapeutics, Inc. | -139.03 Million USD | -74.178% |
| Alnylam Pharmaceuticals, Inc. | -282.17 Million USD | 14.18% |
| AlloVir, Inc. | -181.33 Million USD | -33.547% |
| Arrowhead Pharmaceuticals, Inc. | -205 Million USD | -18.127% |
| VYNE Therapeutics Inc. | -29.25 Million USD | -727.678% |
| Bicycle Therapeutics plc | -189.94 Million USD | -27.49% |
| BioXcel Therapeutics, Inc. | -171.78 Million USD | -40.971% |
| ChromaDex Corporation | -5.59 Million USD | -4225.094% |
| Chimerix, Inc. | -93.06 Million USD | -160.207% |
| Corbus Pharmaceuticals Holdings, Inc. | -45.07 Million USD | -437.215% |
| Caribou Biosciences, Inc. | -116.05 Million USD | -108.654% |
| CRISPR Therapeutics AG | -222.53 Million USD | -8.818% |
| Precision BioSciences, Inc. | -43.73 Million USD | -453.69% |
| Fate Therapeutics, Inc. | -190.51 Million USD | -27.112% |
| Fortress Biotech, Inc. | -142.34 Million USD | -70.127% |
| Fortress Biotech, Inc. | -142.34 Million USD | -70.127% |
| HOOKIPA Pharma Inc. | -97.69 Million USD | -147.878% |
| ImmuCell Corporation | -5.74 Million USD | -4112.921% |
| IDEAYA Biosciences, Inc. | -134.42 Million USD | -80.141% |
| Immix Biopharma, Inc. | -16.14 Million USD | -1400.281% |
| Incyte Corporation | 620.52 Million USD | 139.025% |
| Innoviva, Inc. | 176.7 Million USD | 237.04% |
| IO Biotech, Inc. | -91.44 Million USD | -164.823% |
| Jaguar Health, Inc. | -34.29 Million USD | -606.197% |
| Keros Therapeutics, Inc. | -169.94 Million USD | -42.498% |
| Ligand Pharmaceuticals Incorporated | 11.94 Million USD | 2127.818% |
| ContextLogic Inc. | -328 Million USD | 26.17% |
| MiMedx Group, Inc. | 37.11 Million USD | 752.446% |
| MEI Pharma, Inc. | 14.54 Million USD | 1765.259% |
| NextCure, Inc. | -67.63 Million USD | -258.032% |
| Onconetix, Inc. | -36.03 Million USD | -572.026% |
| Oncternal Therapeutics, Inc. | -41.71 Million USD | -480.529% |
| Opthea Limited | -191.84 Million USD | -26.229% |
| Psyence Biomedical Ltd. | -2.75 Million USD | -8700.051% |
| Vaxcyte, Inc. | -468.04 Million USD | 48.261% |
| PDS Biotechnology Corporation | -43.04 Million USD | -462.576% |
| Precigen, Inc. | -88.92 Million USD | -172.328% |
| Pharming Group N.V. | -4.87 Million USD | -4862.8% |
| Phathom Pharmaceuticals, Inc. | -167.31 Million USD | -44.737% |
| Pieris Pharmaceuticals, Inc. | -29.75 Million USD | -713.826% |
| PureTech Health plc | -146.19 Million USD | -65.639% |
| Rigel Pharmaceuticals, Inc. | -20.49 Million USD | -1081.797% |
| Avidity Biosciences, Inc. | -235.59 Million USD | -2.786% |
| Reviva Pharmaceuticals Holdings, Inc. | -24.3 Million USD | -896.281% |
| Sangamo Therapeutics, Inc. | -274 Million USD | 11.621% |
| Sol-Gel Technologies Ltd. | -29.3 Million USD | -726.35% |
| Acelyrin, Inc. | -422.06 Million USD | 42.624% |
| Salarius Pharmaceuticals, Inc. | -12.89 Thousand USD | -1877861.433% |
| Summit Therapeutics Inc. | -89.73 Million USD | -169.86% |
| Sensei Biotherapeutics, Inc. | -37.06 Million USD | -553.362% |
| Senti Biosciences, Inc. | -92.72 Million USD | -161.156% |
| Stoke Therapeutics, Inc. | -114.77 Million USD | -110.992% |
| Elevation Oncology, Inc. | -45.44 Million USD | -432.868% |
| Alaunos Therapeutics, Inc. | -34.26 Million USD | -606.692% |
| Telomir Pharmaceuticals, Inc. Common Stock | -3.94 Million USD | -6043.051% |
| Entrada Therapeutics, Inc. | -3.16 Million USD | -7558.507% |
| VistaGen Therapeutics, Inc. | -33.02 Million USD | -633.358% |
| Kintara Therapeutics, Inc. | -8.5 Million USD | -2748.63% |
| Wave Life Sciences Ltd. | -67.99 Million USD | -256.142% |
| Seer, Inc. | -103.46 Million USD | -134.057% |
| Verrica Pharmaceuticals Inc. | -65.75 Million USD | -268.257% |
| Aadi Bioscience, Inc. | -71.93 Million USD | -236.649% |
| ESSA Pharma Inc. | -32.13 Million USD | -653.598% |
| GlycoMimetics, Inc. | -39.27 Million USD | -516.576% |
| GT Biopharma, Inc. | -13.57 Million USD | -1683.751% |
| Inhibrx Biosciences, Inc. | -219.22 Million USD | -10.465% |
| Akebia Therapeutics, Inc. | -46.25 Million USD | -423.526% |
| Catalyst Pharmaceuticals, Inc. | 86.81 Million USD | 378.95% |
| Longboard Pharmaceuticals, Inc. | -56.75 Million USD | -326.65% |
| Orchestra BioMed Holdings, Inc. | -51.5 Million USD | -370.163% |
| Alzamend Neuro, Inc. | -9.93 Million USD | -2336.815% |
| Sorrento Therapeutics, Inc. | -504.31 Million USD | 51.982% |
| TRACON Pharmaceuticals, Inc. | -6.89 Million USD | -3410.612% |
| Viracta Therapeutics, Inc. | -50.69 Million USD | -377.703% |
| Rocket Pharmaceuticals, Inc. | -259.65 Million USD | 6.738% |
| Aptose Biosciences Inc. | -52.35 Million USD | -362.53% |
| ZyVersa Therapeutics, Inc. | -14.42 Million USD | -1579.258% |
| Soligenix, Inc. | -7.69 Million USD | -3045.803% |
| Century Therapeutics, Inc. | -146.54 Million USD | -65.246% |
| Kura Oncology, Inc. | -165.8 Million USD | -46.053% |
| TScan Therapeutics, Inc. | -93.45 Million USD | -159.113% |
| Intensity Therapeutics, Inc. | -8.31 Million USD | -2810.951% |
| Ocean Biomedical, Inc. | -2.48 Million USD | -9658.148% |
| CytomX Therapeutics, Inc. | -6.48 Million USD | -3634.762% |
| Autolus Therapeutics plc | -195.02 Million USD | -24.168% |
| Mineralys Therapeutics, Inc. | -84.65 Million USD | -186.051% |
| EyePoint Pharmaceuticals, Inc. | -73.66 Million USD | -228.748% |
| Eterna Therapeutics Inc. | -21.13 Million USD | -1045.787% |
| Adaptive Biotechnologies Corporation | -227.03 Million USD | -6.663% |
| GRI Bio, Inc. | -11.38 Million USD | -2026.653% |
| Xenetic Biosciences, Inc. | -4.51 Million USD | -5262.65% |
| Tenaya Therapeutics, Inc. | -131.19 Million USD | -84.585% |
| IGM Biosciences, Inc. | -263.46 Million USD | 8.084% |
| INmune Bio, Inc. | -29.74 Million USD | -714.236% |
| Heron Therapeutics, Inc. | -110.61 Million USD | -118.923% |
| SAB Biotherapeutics, Inc. | -38.07 Million USD | -536.008% |
| Pasithea Therapeutics Corp. | -15.97 Million USD | -1415.467% |
| Entero Therapeutics, Inc. | -15.77 Million USD | -1435.506% |
| Milestone Pharmaceuticals Inc. | -61.09 Million USD | -296.35% |
| X4 Pharmaceuticals, Inc. | -107.52 Million USD | -125.221% |
| Atara Biotherapeutics, Inc. | -276 Million USD | 12.262% |
| Coherus BioSciences, Inc. | -203.19 Million USD | -19.175% |
| Verastem, Inc. | -92.08 Million USD | -162.979% |
| Abeona Therapeutics Inc. | -47.13 Million USD | -413.763% |
| Pliant Therapeutics, Inc. | -184.14 Million USD | -31.506% |
| Tonix Pharmaceuticals Holding Corp. | -118.38 Million USD | -104.563% |
| Histogen Inc. | -10.64 Million USD | -2175.317% |
| Aprea Therapeutics, Inc. | -15.47 Million USD | -1465.167% |
| Surrozen, Inc. | -45.78 Million USD | -428.969% |
| Organovo Holdings, Inc. | -15.08 Million USD | -1505.21% |
| Lixte Biotechnology Holdings, Inc. | -5.09 Million USD | -4657.383% |
| Ovid Therapeutics Inc. | -59.28 Million USD | -308.495% |
| Panbela Therapeutics, Inc. | -51.29 Million USD | -372.106% |
| CASI Pharmaceuticals, Inc. | -25.28 Million USD | -857.919% |
| Cadrenal Therapeutics, Inc. Common Stock | -7.63 Million USD | -3072.632% |
| Centessa Pharmaceuticals plc | -171.28 Million USD | -41.381% |
| Hepion Pharmaceuticals, Inc. | -48.44 Million USD | -399.839% |
| Arcturus Therapeutics Holdings Inc. | -78.2 Million USD | -209.65% |
| BioRestorative Therapies, Inc. | -15.22 Million USD | -1490.997% |
| Apollomics, Inc. | -54.83 Million USD | -341.627% |
| Amarin Corporation plc | -67.58 Million USD | -258.291% |
| Mesoblast Limited | -58.79 Million USD | -311.882% |
| Turnstone Biologics Corp. | -59.03 Million USD | -310.222% |
| Kymera Therapeutics, Inc. | -165.53 Million USD | -46.295% |
| Synaptogenix, Inc. | -8.31 Million USD | -2812.753% |
| Tiziana Life Sciences Ltd | -14.58 Million USD | -1560.236% |
| Aurinia Pharmaceuticals Inc. | -91.69 Million USD | -164.107% |
| BriaCell Therapeutics Corp. | -4.79 Million USD | -4954.027% |
| Monopar Therapeutics Inc. | -8.83 Million USD | -2642.108% |
| Exelixis, Inc. | 170.88 Million USD | 241.711% |
| Better Therapeutics, Inc. | -38.26 Million USD | -532.905% |
| Nurix Therapeutics, Inc. | -155.06 Million USD | -56.17% |
| Apellis Pharmaceuticals, Inc. | -517.12 Million USD | 53.171% |
| NLS Pharmaceutics AG | -11.8 Million USD | -1950.993% |
| Dermata Therapeutics, Inc. | -8.04 Million USD | -2911.251% |
| Aridis Pharmaceuticals, Inc. | -29.99 Million USD | -707.395% |
| Gritstone bio, Inc. | -154.63 Million USD | -56.603% |
| Jasper Therapeutics, Inc. | -68.86 Million USD | -251.668% |
| TNF Pharmaceuticals, Inc. | -17.12 Million USD | -1314.246% |
| Avid Bioservices, Inc. | -18.67 Million USD | -1196.509% |
| Insmed Incorporated | -709.62 Million USD | 65.875% |
| Virpax Pharmaceuticals, Inc. | -15.68 Million USD | -1443.437% |
| MediWound Ltd. | -15.29 Million USD | -1483.793% |
| OmniAb, Inc. | -69.41 Million USD | -248.841% |
| Alector, Inc. | -151.74 Million USD | -59.59% |
| Seres Therapeutics, Inc. | -107.98 Million USD | -124.259% |
| Checkpoint Therapeutics, Inc. | -52.14 Million USD | -364.374% |
| Zai Lab Limited | -366.57 Million USD | 33.939% |
| Revance Therapeutics, Inc. | -316.77 Million USD | 23.554% |
| Aura Biosciences, Inc. | -84.99 Million USD | -184.927% |
| Lyell Immunopharma, Inc. | -245.49 Million USD | 1.359% |
| Immunic, Inc. | -99.22 Million USD | -144.058% |
| Tarsus Pharmaceuticals, Inc. | -143.15 Million USD | -69.157% |
| Veracyte, Inc. | -85.79 Million USD | -182.257% |
| InMed Pharmaceuticals Inc. | - USD | Infinity% |
| FibroGen, Inc. | -281.81 Million USD | 14.071% |
| SeaStar Medical Holding Corporation | -14.21 Million USD | -1604.166% |
| Adial Pharmaceuticals, Inc. | -6.88 Million USD | -3415.736% |
| Sonnet BioTherapeutics Holdings, Inc. | -18.79 Million USD | -1188.602% |
| Jazz Pharmaceuticals plc | 578.58 Million USD | 141.855% |
| Cyclacel Pharmaceuticals, Inc. | -25.45 Million USD | -851.408% |
| Amylyx Pharmaceuticals, Inc. | 38.8 Million USD | 724.097% |
| TG Therapeutics, Inc. | 20.63 Million USD | 1273.664% |
| Galecto, Inc. | -39.9 Million USD | -506.846% |
| Calithera Biosciences, Inc. | -42.07 Million USD | -475.562% |
| Fortrea Holdings Inc. | 63.1 Million USD | 483.775% |
| KalVista Pharmaceuticals, Inc. | -140.44 Million USD | -72.425% |
| Aptevo Therapeutics Inc. | -28.87 Million USD | -738.569% |
| XBiotech Inc. | -37.51 Million USD | -545.593% |
| Jasper Therapeutics, Inc. | -68.86 Million USD | -251.668% |
| Lyra Therapeutics, Inc. | -67.12 Million USD | -260.79% |
| Foghorn Therapeutics Inc. | -107.9 Million USD | -124.419% |
| Y-mAbs Therapeutics, Inc. | -25.67 Million USD | -843.292% |
| Theravance Biopharma, Inc. | -53.29 Million USD | -354.406% |
| Ultragenyx Pharmaceutical Inc. | -569.2 Million USD | 57.456% |
| Metagenomi, Inc. Common Stock | -78.49 Million USD | -208.518% |
| Vaxxinity, Inc. | -58.28 Million USD | -315.479% |
| BioCryst Pharmaceuticals, Inc. | -103.7 Million USD | -133.501% |
| Gain Therapeutics, Inc. | -22.25 Million USD | -988.215% |
| Cartesian Therapeutics, Inc. | -86.41 Million USD | -180.228% |
| NexImmune, Inc. | -29.19 Million USD | -729.536% |
| Creative Medical Technology Holdings, Inc. | -5.62 Million USD | -4208.831% |
| Marker Therapeutics, Inc. | -14.58 Million USD | -1560.762% |
| Regeneron Pharmaceuticals, Inc. | 4.04 Billion USD | 105.984% |
| Chemomab Therapeutics Ltd. | -25.45 Million USD | -851.184% |
| Scopus BioPharma Inc. | -11.71 Million USD | -1967.132% |
| RAPT Therapeutics, Inc. | -127.06 Million USD | -90.586% |
| Ainos, Inc. | -13.2 Million USD | -1733.672% |
| Pluri Inc. | -22.15 Million USD | -992.887% |
| Prothena Corporation plc | -191.03 Million USD | -26.762% |
| Adaptimmune Therapeutics plc | -138.03 Million USD | -75.431% |
| Celularity Inc. | -192.28 Million USD | -25.938% |
| Rallybio Corporation | -78.93 Million USD | -206.798% |
| Cue Biopharma, Inc. | -52.14 Million USD | -364.366% |
| MeiraGTx Holdings plc | -137.06 Million USD | -76.682% |
| Omeros Corporation | -164.53 Million USD | -47.184% |
| Humacyte, Inc. | -100.04 Million USD | -142.048% |
| Immunocore Holdings plc | -59.64 Million USD | -305.978% |
| Cocrystal Pharma, Inc. | -18.55 Million USD | -1204.822% |
| Cidara Therapeutics, Inc. | -24.48 Million USD | -889.103% |
| Blueprint Medicines Corporation | -486.27 Million USD | 50.201% |
| CalciMedica, Inc. | -21.87 Million USD | -1007.026% |
| Cabaletta Bio, Inc. | -74.66 Million USD | -224.353% |
| Marinus Pharmaceuticals, Inc. | -131.48 Million USD | -84.175% |
| Scholar Rock Holding Corporation | -171.29 Million USD | -41.371% |
| Sana Biotechnology, Inc. | -326.9 Million USD | 25.922% |
| Pulmatrix, Inc. | -14.74 Million USD | -1542.89% |
| Elicio Therapeutics, Inc. | -35.74 Million USD | -577.471% |
| Vigil Neuroscience, Inc. | -88.86 Million USD | -172.502% |
| Intellia Therapeutics, Inc. | -515.29 Million USD | 53.005% |
| Adlai Nortye Ltd. American Depositary Shares | -67.55 Million USD | -258.488% |
| Cytokinetics, Incorporated | -496.2 Million USD | 51.197% |
| Eloxx Pharmaceuticals, Inc. | -34.41 Million USD | -603.571% |
| Nutriband Inc. | -4.87 Million USD | -4870.56% |
| Protara Therapeutics, Inc. | -43.61 Million USD | -455.252% |
| Vor Biopharma Inc. | -126.03 Million USD | -92.137% |
| Roivant Sciences Ltd. | 4.24 Billion USD | 105.709% |
| Evogene Ltd. | -26.39 Million USD | -817.593% |
| ProKidney Corp. | -151.52 Million USD | -59.82% |
| Applied Therapeutics, Inc. | -64.53 Million USD | -275.241% |
| Hoth Therapeutics, Inc. | -7.69 Million USD | -3048.133% |
| BridgeBio Pharma, Inc. | -607.37 Million USD | 60.129% |
| CorMedix Inc. | -48.95 Million USD | -394.634% |
| BioLineRx Ltd. | -49.69 Million USD | -387.306% |
| Tango Therapeutics, Inc. | -114.17 Million USD | -112.101% |
| Galectin Therapeutics Inc. | -38.07 Million USD | -536.063% |
| Atai Life Sciences N.V. | -125.47 Million USD | -93.002% |
| Renovaro Biosciences Inc. | -81.63 Million USD | -196.624% |
| Aerovate Therapeutics, Inc. | -81.4 Million USD | -197.463% |
| Zentalis Pharmaceuticals, Inc. | -248.98 Million USD | 2.741% |
| Sagimet Biosciences Inc. | -30.74 Million USD | -687.775% |
| MediciNova, Inc. | -9.9 Million USD | -2346.015% |
| Praxis Precision Medicines, Inc. | -126.37 Million USD | -91.625% |
| Cardio Diagnostics Holdings, Inc. | -7.24 Million USD | -3243.643% |
| GeoVax Labs, Inc. | -26.74 Million USD | -805.518% |
| Axsome Therapeutics, Inc. | -231.82 Million USD | -4.459% |
| Biomea Fusion, Inc. | -126.13 Million USD | -91.986% |
| PTC Therapeutics, Inc. | -349.4 Million USD | 30.692% |
| Mereo BioPharma Group plc | -28.41 Million USD | -752.203% |
| Cullinan Oncology, Inc. | -191.08 Million USD | -26.727% |
| Syndax Pharmaceuticals, Inc. | -229.95 Million USD | -5.309% |
| Absci Corporation | -115.51 Million USD | -109.637% |
| NRx Pharmaceuticals, Inc. | -27.58 Million USD | -777.812% |
| 4D Molecular Therapeutics, Inc. | -112.86 Million USD | -114.555% |
| Kiniksa Pharmaceuticals, Ltd. | -25.19 Million USD | -861.113% |
| Ventyx Biosciences, Inc. | -207.99 Million USD | -16.427% |
| Allakos Inc. | -196.05 Million USD | -23.517% |
| Imunon, Inc. | -21.03 Million USD | -1051.484% |
| Fulcrum Therapeutics, Inc. | -110.66 Million USD | -118.826% |
| Corcept Therapeutics Incorporated | 107.28 Million USD | 325.725% |
| BioAtla, Inc. | -129.68 Million USD | -86.728% |
| NLS Pharmaceutics AG | -11.8 Million USD | -1950.993% |
| Bio-Path Holdings, Inc. | -15.84 Million USD | -1428.511% |
| Allogene Therapeutics, Inc. | -327.73 Million USD | 26.111% |
| Larimar Therapeutics, Inc. | -41.75 Million USD | -479.918% |
| XOMA Corporation | -41.84 Million USD | -478.67% |
| Kezar Life Sciences, Inc. | -105.23 Million USD | -130.111% |
| Cara Therapeutics, Inc. | -121.49 Million USD | -99.318% |
| aTyr Pharma, Inc. | -54.91 Million USD | -340.944% |
| Aligos Therapeutics, Inc. | -87.42 Million USD | -176.988% |
| Akero Therapeutics, Inc. | -172.87 Million USD | -40.083% |
| Viridian Therapeutics, Inc. | -254.45 Million USD | 4.829% |
| Eliem Therapeutics, Inc. | -21.46 Million USD | -1028.119% |
| EyeGate Pharmaceuticals, Inc. | -8.21 Million USD | -2848.609% |
| Akari Therapeutics, Plc | -16.8 Million USD | -1340.926% |
| Tevogen Bio Holdings Inc. | -8843.03 USD | -2738350.508% |
| Halozyme Therapeutics, Inc. | 337.57 Million USD | 171.736% |
| Lexaria Bioscience Corp. | -6.53 Million USD | -3606.171% |
| UroGen Pharma Ltd. | -65.53 Million USD | -269.51% |
| Sutro Biopharma, Inc. | -89.27 Million USD | -171.245% |
| ZIVO Bioscience, Inc. | -7.26 Million USD | -3234.181% |
| Orgenesis Inc. | -53.63 Million USD | -351.492% |
| Entera Bio Ltd. | -8.89 Million USD | -2623.676% |
| GH Research PLC | -41.22 Million USD | -487.458% |
| Lisata Therapeutics, Inc. | -25.7 Million USD | -841.971% |
| Reneo Pharmaceuticals, Inc. | -83.05 Million USD | -191.575% |
| Xencor, Inc. | -138.63 Million USD | -74.671% |
| 60 Degrees Pharmaceuticals, Inc. | -5.15 Million USD | -4597.994% |
| Replimune Group, Inc. | -234.77 Million USD | -3.147% |
| Coeptis Therapeutics Holdings, Inc. | -21.49 Million USD | -1026.8% |
| Vanda Pharmaceuticals Inc. | -13.95 Million USD | -1635.679% |
| Lexaria Bioscience Corp. | -6.53 Million USD | -3606.171% |
| Portage Biotech Inc. | -18.25 Million USD | -1226.697% |
| Cardio Diagnostics Holdings, Inc. | -7.24 Million USD | -3243.643% |
| Olema Pharmaceuticals, Inc. | -104.96 Million USD | -130.716% |
| OncoCyte Corporation | -25.13 Million USD | -863.407% |
| Qualigen Therapeutics, Inc. | -11.3 Million USD | -2042.106% |
| Processa Pharmaceuticals, Inc. | -11.45 Million USD | -2013.649% |
| Purple Biotech Ltd. | 22.27 Million USD | 1187.342% |
| CollPlant Biotechnologies Ltd. | -7.51 Million USD | -3123.669% |
| scPharmaceuticals Inc. | -55.39 Million USD | -337.147% |
| ProMIS Neurosciences, Inc. | -18.89 Million USD | -1181.437% |
| HilleVax, Inc. | -133.34 Million USD | -81.606% |
| NeuroSense Therapeutics Ltd. | -12.04 Million USD | -1909.81% |
| Tharimmune, Inc. | -9.45 Million USD | -2461.146% |
| Genprex, Inc. | -31.07 Million USD | -679.268% |
| Neumora Therapeutics, Inc. Common Stock | -188.19 Million USD | -28.677% |
| Atossa Therapeutics, Inc. | -31.37 Million USD | -671.782% |
| XTL Biopharmaceuticals Ltd. | -765 Thousand USD | -31555.163% |
| Virios Therapeutics, Inc. | -5.44 Million USD | -4345.853% |
| OKYO Pharma Limited | -15.74 Thousand USD | -1537462.866% |
| Savara Inc. | -60 Million USD | -303.556% |
| Curis, Inc. | -48.33 Million USD | -401.039% |
| Daré Bioscience, Inc. | -30.83 Million USD | -685.224% |
| Carmell Therapeutics Corporation | -5.21 Million USD | -4541.537% |
| Titan Pharmaceuticals, Inc. | -7.27 Million USD | -3227.772% |
| Achieve Life Sciences, Inc. | -27.25 Million USD | -788.668% |
| BeiGene, Ltd. | -1.2 Billion USD | 79.949% |
| Kiromic BioPharma, Inc. | -19.93 Million USD | -1114.496% |
| Revolution Medicines, Inc. Warrant | -487.18 Million USD | 50.294% |
| Protagonist Therapeutics, Inc. | -93.65 Million USD | -158.576% |
| Erasca, Inc. | -141.52 Million USD | -71.109% |
| bluebird bio, Inc. | -244.26 Million USD | 0.86% |
| Protagenic Therapeutics, Inc. | -4.52 Million USD | -5249.313% |
| BioMarin Pharmaceutical Inc. | 194.44 Million USD | 224.543% |
| DBV Technologies S.A. | -76.43 Million USD | -216.833% |
| Protagenic Therapeutics, Inc. | -4.52 Million USD | -5249.313% |
| Moderna, Inc. | -4.23 Billion USD | 94.287% |
| Vincerx Pharma, Inc. | -42.6 Million USD | -468.335% |
| Fresh Tracks Therapeutics, Inc. | -6.36 Million USD | -3707.579% |
| Molecular Templates, Inc. | -10.46 Million USD | -2213.797% |
| Acrivon Therapeutics, Inc. Common Stock | -67.23 Million USD | -260.162% |
| Travere Therapeutics, Inc. | -376.74 Million USD | 35.722% |
| Monte Rosa Therapeutics, Inc. | -143.31 Million USD | -68.977% |
| Spruce Biosciences, Inc. | -51.99 Million USD | -365.759% |
| Celldex Therapeutics, Inc. | -154.54 Million USD | -56.697% |
| Cogent Biosciences, Inc. | -208.13 Million USD | -16.351% |
| MacroGenics, Inc. | -168.24 Million USD | -43.935% |
| RenovoRx, Inc. | -11.39 Million USD | -2024.974% |
| Adicet Bio, Inc. | -152.03 Million USD | -59.277% |
| Prime Medicine, Inc. | -191.29 Million USD | -26.593% |
| Aditxt, Inc. | -26.06 Million USD | -829.161% |
| Adagene Inc. | -23.71 Million USD | -920.925% |
| Estrella Immunopharma, Inc. | -7.31 Million USD | -3212.705% |
| Quantum-Si incorporated | -111.17 Million USD | -117.828% |
| Maravai LifeSciences Holdings, Inc. | -31.64 Million USD | -665.173% |
| Acurx Pharmaceuticals, Inc. | -14.57 Million USD | -1561.173% |
| Voyager Therapeutics, Inc. | 122.01 Million USD | 298.471% |
| SciSparc Ltd. | -5.77 Million USD | -4094.734% |
| Vericel Corporation | -6.46 Million USD | -3646.318% |
| Revelation Biosciences, Inc. | -8.65 Million USD | -2697.406% |
| Minerva Neurosciences, Inc. | -23.11 Million USD | -947.433% |
| Generation Bio Co. | -138.56 Million USD | -74.767% |
| Astria Therapeutics, Inc. | -83.03 Million USD | -191.656% |
| Black Diamond Therapeutics, Inc. | -86.46 Million USD | -180.086% |
| Arcutis Biotherapeutics, Inc. | -241.1 Million USD | -0.44% |
| Invivyd, Inc. | -207.78 Million USD | -16.546% |
| Relay Therapeutics, Inc. | -373 Million USD | 35.077% |
| Quoin Pharmaceuticals, Ltd. | -9.37 Million USD | -2482.096% |
| Spero Therapeutics, Inc. | 21.48 Million USD | 1227.331% |
| Artelo Biosciences, Inc. | -10.28 Million USD | -2254.059% |
| 2seventy bio, Inc. | -216.7 Million USD | -11.748% |
| ADMA Biologics, Inc. | 21.63 Million USD | 1219.462% |
| Clene Inc. | -40.54 Million USD | -497.341% |
| Capricor Therapeutics, Inc. | -24.07 Million USD | -905.746% |
| Boundless Bio, Inc. Common Stock | -54.79 Million USD | -341.934% |
| GeoVax Labs, Inc. | -26.74 Million USD | -805.518% |
| Recursion Pharmaceuticals, Inc. | -350.06 Million USD | 30.823% |
| Citius Pharmaceuticals, Inc. | -36.73 Million USD | -559.267% |
| Contineum Therapeutics, Inc. Class A Common Stock | 16.07 Million USD | 1606.264% |
| Relmada Therapeutics, Inc. | -103.7 Million USD | -133.517% |
| Finch Therapeutics Group, Inc. | -34 Million USD | -612.199% |
| ALX Oncology Holdings Inc. | -170.27 Million USD | -42.216% |
| Vir Biotechnology, Inc. | -684.3 Million USD | 64.612% |
| Evaxion Biotech A/S | -22.19 Million USD | -990.967% |
| Ocular Therapeutix, Inc. | -82.38 Million USD | -193.95% |
| Verve Therapeutics, Inc. | -223.12 Million USD | -8.532% |
| Trevena, Inc. | -35.28 Million USD | -586.245% |
| Surrozen, Inc. | -45.78 Million USD | -428.969% |
| Tyra Biosciences, Inc. | -79.94 Million USD | -202.911% |
| Cingulate Inc. | -22.75 Million USD | -964.019% |
| Galmed Pharmaceuticals Ltd. | 7.49 Million USD | 3332.274% |
| Unity Biotechnology, Inc. | -44.66 Million USD | -442.15% |
| Tenax Therapeutics, Inc. | -8.23 Million USD | -2841.022% |
| Terns Pharmaceuticals, Inc. | -102.55 Million USD | -136.122% |
| ACADIA Pharmaceuticals Inc. | -73.37 Million USD | -230.015% |
| Connect Biopharma Holdings Limited | -62.07 Million USD | -290.118% |
| Clearmind Medicine Inc. | -8.74 Million USD | -2670.304% |
| Kronos Bio, Inc. | -121.83 Million USD | -98.77% |
| Bolt Biotherapeutics, Inc. | -76.19 Million USD | -217.815% |
| CERo Therapeutics Holdings, Inc. | -2.93 Million USD | -8156.503% |
| Viking Therapeutics, Inc. | -100.82 Million USD | -140.176% |
| Statera Biopharma, Inc. | -98.34 Million USD | -146.24% |
| ImmunityBio, Inc. | -362.25 Million USD | 33.151% |
| Korro Bio, Inc. | -84.53 Million USD | -186.467% |
| Kineta, Inc. | -15.72 Million USD | -1440.177% |
| BioVie Inc. | -32.17 Million USD | -652.533% |
| Codexis, Inc. | -68.06 Million USD | -255.76% |
| Celularity Inc. | -192.28 Million USD | -25.938% |
| Crinetics Pharmaceuticals, Inc. | -222.6 Million USD | -8.784% |
| Celcuity Inc. | -66.23 Million USD | -265.636% |
| Virax Biolabs Group Limited | -6.49 Million USD | -3627.592% |
| Cibus, Inc. | -318.88 Million USD | 24.059% |
| Eledon Pharmaceuticals, Inc. | -43 Million USD | -463.167% |
| eFFECTOR Therapeutics, Inc. | -33.84 Million USD | -615.524% |
| IN8bio, Inc. | -30.33 Million USD | -698.24% |
| Kodiak Sciences Inc. | -277.32 Million USD | 12.678% |
| Annexon, Inc. | -143.72 Million USD | -68.492% |
| Adverum Biotechnologies, Inc. | -123.79 Million USD | -95.622% |
| Assembly Biosciences, Inc. | -64.64 Million USD | -274.597% |
| Avalo Therapeutics, Inc. | -23.44 Million USD | -932.938% |
| Ionis Pharmaceuticals, Inc. | -353.73 Million USD | 31.54% |
| Eyenovia, Inc. | -25.4 Million USD | -853.152% |
| Puma Biotechnology, Inc. | 32.64 Million USD | 841.918% |
| Conduit Pharmaceuticals Inc. | -5.56 Million USD | -4253.866% |
| Xilio Therapeutics, Inc. | -79.13 Million USD | -206.019% |
| Arcellx, Inc. | -89.88 Million USD | -169.428% |
| Cardiff Oncology, Inc. | -45.41 Million USD | -433.256% |
| Enanta Pharmaceuticals, Inc. | -137.2 Million USD | -76.494% |
| Regulus Therapeutics Inc. | -31.1 Million USD | -678.431% |
| Moolec Science SA | -6.65 Million USD | -3539.451% |
| Acumen Pharmaceuticals, Inc. | -61.13 Million USD | -296.091% |
| Geron Corporation | -193.94 Million USD | -24.862% |
| LAVA Therapeutics N.V. | -43.25 Million USD | -459.873% |
| Royalty Pharma plc | 1.49 Billion USD | 116.229% |
| Atea Pharmaceuticals, Inc. | -164.16 Million USD | -47.514% |
| Greenwich LifeSciences, Inc. | -9.32 Million USD | -2496.114% |
| TFF Pharmaceuticals, Inc. | -21.89 Million USD | -1006.032% |
| Mersana Therapeutics, Inc. | -170.95 Million USD | -41.651% |
| Humacyte, Inc. | -100.04 Million USD | -142.048% |
| Structure Therapeutics Inc. | -102.77 Million USD | -135.623% |
| 89bio, Inc. | -151.2 Million USD | -60.156% |
| PMV Pharmaceuticals, Inc. | -80.13 Million USD | -202.204% |
| Avenue Therapeutics, Inc. | -14.54 Million USD | -1565.488% |
| Genelux Corporation | -24.16 Million USD | -902.119% |
| Trevi Therapeutics, Inc. | -33.92 Million USD | -613.858% |
| Lexicon Pharmaceuticals, Inc. | -171.75 Million USD | -40.997% |
| Notable Labs, Ltd. | -14.65 Million USD | -1552.193% |
| Liquidia Corporation | -73.38 Million USD | -229.993% |
| Mustang Bio, Inc. | -50.72 Million USD | -377.392% |
| Immunovant, Inc. | -282.7 Million USD | 14.342% |
| Quantum-Si incorporated | -111.17 Million USD | -117.828% |
| Arbutus Biopharma Corporation | -78.1 Million USD | -210.055% |
| DiaMedica Therapeutics Inc. | -21.26 Million USD | -1038.675% |
| Vera Therapeutics, Inc. | -102.01 Million USD | -137.386% |
| Acasti Pharma Inc. | -11.31 Million USD | -2040.753% |
| MiNK Therapeutics, Inc. | -22.92 Million USD | -956.502% |
| Pasithea Therapeutics Corp. | -15.97 Million USD | -1415.467% |
| Xenon Pharmaceuticals Inc. | -214.05 Million USD | -13.131% |
| Elevai Labs, Inc. Common Stock | -3.66 Million USD | -6500.089% |
| NeuroBo Pharmaceuticals, Inc. | -15.88 Million USD | -1424.374% |
| Tempest Therapeutics, Inc. | -29.15 Million USD | -730.545% |
| Soleno Therapeutics, Inc. | -41.38 Million USD | -485.159% |
| PepGen Inc. | -84.76 Million USD | -185.683% |
| Moleculin Biotech, Inc. | -29.63 Million USD | -717.259% |
| United Therapeutics Corporation | 1.18 Billion USD | 120.437% |
| Nuvectis Pharma, Inc. | -22.89 Million USD | -957.615% |
| Solid Biosciences Inc. | -104.31 Million USD | -132.145% |
| BriaCell Therapeutics Corp. | -32.8 Million USD | -638.116% |
| Immuneering Corporation | -58.41 Million USD | -314.569% |
| Lixte Biotechnology Holdings, Inc. | -5.09 Million USD | -4657.383% |
| Silo Pharma, Inc. | -3.85 Million USD | -6180.799% |
| Belite Bio, Inc | -31.66 Million USD | -664.69% |
| XOMA Corporation | -41.84 Million USD | -478.67% |
| ARS Pharmaceuticals, Inc. | -67.52 Million USD | -258.652% |
| Bionomics Limited | -17.89 Billion USD | 98.647% |
| Apogee Therapeutics, Inc. | -93 Million USD | -160.381% |
| Alpha Tau Medical Ltd. | 35.68 Million USD | 778.705% |
| uniQure N.V. | -282.87 Million USD | 14.391% |
| Cassava Sciences, Inc. | -105.95 Million USD | -128.547% |
| Estrella Immunopharma, Inc. | -7.31 Million USD | -3212.705% |
| Poseida Therapeutics, Inc. | -129.5 Million USD | -86.992% |
| Forte Biosciences, Inc. | -32.48 Million USD | -645.435% |
| Anebulo Pharmaceuticals, Inc. | -8.3 Million USD | -2814.54% |
| Enlivex Therapeutics Ltd. | -29.39 Million USD | -723.82% |
| Conduit Pharmaceuticals Inc. | -5.56 Million USD | -4253.866% |
| SeaStar Medical Holding Corporation | -14.21 Million USD | -1604.166% |
| FibroBiologics, Inc. Common Stock | -8.88 Million USD | -2624.288% |
| Altimmune, Inc. | -95.92 Million USD | -152.439% |
| Amicus Therapeutics, Inc. | -73.49 Million USD | -229.499% |
| Alpha Tau Medical Ltd. | 35.68 Million USD | 778.705% |
| Compugen Ltd. | -12.99 Million USD | -1763.932% |
| Peak Bio, Inc. | -1356.23 USD | -17855425.98% |
| Zevra Therapeutics, Inc. | -49.6 Million USD | -388.19% |
| Benitec Biopharma Inc. | -22.49 Million USD | -976.754% |
| Spyre Therapeutics, Inc. | -242.3 Million USD | 0.058% |
| NKGen Biotech, Inc. Common Stock | -29.74 Million USD | -714.099% |
| Zura Bio Limited | -62.63 Million USD | -286.606% |
| PolyPid Ltd. | -22.86 Million USD | -959.002% |
| Aileron Therapeutics, Inc. | -16.27 Million USD | -1387.847% |
| NKGen Biotech, Inc. Warrants | -29.74 Million USD | -714.099% |
| Instil Bio, Inc. | -159.16 Million USD | -52.141% |
| argenx SE | -425.04 Million USD | 43.027% |
| Immunome, Inc. | -109.53 Million USD | -121.092% |
| Compass Therapeutics, Inc. | -50.36 Million USD | -380.833% |
| Verona Pharma plc | -67.83 Million USD | -257.008% |
| enGene Holdings Inc. Warrants | -26.06 Million USD | -829.248% |
| Shattuck Labs, Inc. | -91.95 Million USD | -163.343% |
| CervoMed Inc. | -7.81 Million USD | -2999.517% |
| LENZ Therapeutics, Inc. | -73.11 Million USD | -231.23% |
| Plus Therapeutics, Inc. | -13.32 Million USD | -1717.897% |
| Dianthus Therapeutics, Inc. | -48.17 Million USD | -402.682% |
| Moolec Science SA | -6.65 Million USD | -3539.451% |
| Enveric Biosciences, Inc. | -16.44 Million USD | -1372.249% |
| Inovio Pharmaceuticals, Inc. | -135.22 Million USD | -79.079% |
| AnaptysBio, Inc. | -164.41 Million USD | -47.291% |
| Design Therapeutics, Inc. | -78.19 Million USD | -209.71% |
| Leap Therapeutics, Inc. | -87.04 Million USD | -178.216% |
| NeurAxis, Inc. | -6.66 Million USD | -3533.614% |
| Seelos Therapeutics, Inc. | -40.49 Million USD | -497.946% |
| Lumos Pharma, Inc. | -36.61 Million USD | -561.392% |
| Achilles Therapeutics plc | -75.25 Million USD | -221.789% |
| enGene Holdings Inc. Common Stock | -26.06 Million USD | -829.248% |
| 180 Life Sciences Corp. | -13.47 Million USD | -1696.787% |
| Opiant Pharmaceuticals, Inc. | 5.15 Million USD | 4796.42% |
| CERo Therapeutics Holdings, Inc. | -2.93 Million USD | -8156.503% |
| Nutriband Inc. | -4.87 Million USD | -4870.56% |
| ORIC Pharmaceuticals, Inc. | -110.78 Million USD | -118.597% |
| CG Oncology, Inc. Common stock | -55.44 Million USD | -336.729% |
| Fractyl Health, Inc. Common Stock | -50.83 Million USD | -376.359% |
| Rani Therapeutics Holdings, Inc. | -66.09 Million USD | -266.363% |
| MoonLake Immunotherapeutics | -54.12 Million USD | -347.428% |
| Palisade Bio, Inc. | -13.07 Million USD | -1752.808% |
| Tourmaline Bio, Inc. | -45.4 Million USD | -433.291% |
| Beam Therapeutics Inc. | -176.48 Million USD | -37.214% |
| Neurogene Inc. | -55.58 Million USD | -335.676% |
| Mirum Pharmaceuticals, Inc. | -109.15 Million USD | -121.854% |
| AEON Biopharma, Inc. | -48.42 Million USD | -400.035% |
| CARGO Therapeutics, Inc. Common Stock | -96.71 Million USD | -150.4% |
| Sesen Bio, Inc. | -25.9 Million USD | -834.664% |
| Enliven Therapeutics, Inc. | -83.52 Million USD | -189.914% |
| Kiora Pharmaceuticals, Inc. | -12.58 Million USD | -1823.922% |
| Iovance Biotherapeutics, Inc. | -460.55 Million USD | 47.42% |
| Taysha Gene Therapies, Inc. | -72.43 Million USD | -234.298% |
| Athira Pharma, Inc. | -125.46 Million USD | -93.01% |
| Vaccinex, Inc. | -22.88 Million USD | -958.169% |
| HCW Biologics Inc. | -25.71 Million USD | -841.636% |
| XOMA Corporation | -41.84 Million USD | -478.67% |
| Nektar Therapeutics | -137.42 Million USD | -76.214% |
| Arvinas, Inc. | -401.5 Million USD | 39.686% |
| Tevogen Bio Holdings Inc. | -8843.03 USD | -2738350.508% |
| Merus N.V. | -156.54 Million USD | -54.69% |
| Omega Therapeutics, Inc. | -100.26 Million USD | -141.532% |
| Quince Therapeutics, Inc. | -34.62 Million USD | -599.486% |
| Rezolute, Inc. | -70.42 Million USD | -243.868% |
| Clene Inc. | -40.54 Million USD | -497.341% |
| Indaptus Therapeutics, Inc. | -16.37 Million USD | -1378.538% |
| BeyondSpring Inc. | -23.11 Million USD | -947.685% |
| Synlogic, Inc. | -55.16 Million USD | -339.009% |
| Allarity Therapeutics, Inc. | -17.92 Million USD | -1250.672% |
| Phio Pharmaceuticals Corp. | -10.82 Million USD | -2137.269% |
| Peak Bio, Inc. | -1356.23 USD | -17855425.98% |
| Werewolf Therapeutics, Inc. | -40.5 Million USD | -497.887% |
| Krystal Biotech, Inc. | -109.72 Million USD | -120.695% |
| Karyopharm Therapeutics Inc. | -129.53 Million USD | -86.94% |
| SpringWorks Therapeutics, Inc. | -343.01 Million USD | 29.402% |
| Lipella Pharmaceuticals Inc. | -4.74 Million USD | -5002.495% |
| MannKind Corporation | 8.67 Million USD | 2890.528% |
| Ikena Oncology, Inc. | -75.41 Million USD | -221.097% |
| Cyclerion Therapeutics, Inc. | -9.64 Million USD | -2410.231% |
| Gyre Therapeutics, Inc. | -67.23 Million USD | -260.199% |
| Gossamer Bio, Inc. | -183.75 Million USD | -31.782% |
| CohBar, Inc. | -12.38 Million USD | -1854.764% |
| Cognition Therapeutics, Inc. | -50.72 Million USD | -377.411% |
| NRx Pharmaceuticals, Inc. | -27.58 Million USD | -777.812% |
| Legend Biotech Corporation | -439.48 Million USD | 44.899% |
| Mural Oncology plc | -194.63 Million USD | -24.417% |
| Biora Therapeutics, Inc. | -67.14 Million USD | -260.666% |
| PaxMedica, Inc. Common Stock | -16.14 Million USD | -1399.894% |
| Disc Medicine, Inc. | -91.12 Million USD | -165.747% |
| Champions Oncology, Inc. | -7.35 Million USD | -3192.034% |
| REGENXBIO Inc. | -268.12 Million USD | 9.684% |
| Ensysce Biosciences, Inc. | -10.71 Million USD | -2159.356% |
| Anavex Life Sciences Corp. | -55.75 Million USD | -334.325% |
| Cellectar Biosciences, Inc. | -38.96 Million USD | -521.555% |
| Edgewise Therapeutics, Inc. | -114.35 Million USD | -111.76% |
| Vaxart, Inc. | -83.34 Million USD | -190.547% |
| PharmaCyte Biotech, Inc. | -8.52 Million USD | -2742.274% |
| Aldeyra Therapeutics, Inc. | -42.79 Million USD | -465.877% |
| Cellectis S.A. | -106.62 Million USD | -127.113% |
| Longeveron Inc. | -21.02 Million USD | -1051.562% |
| Repare Therapeutics Inc. | -116.22 Million USD | -108.358% |
| Sarepta Therapeutics, Inc. | -267.82 Million USD | 9.582% |
| Inozyme Pharma, Inc. | -75.64 Million USD | -220.13% |
| Revolution Medicines, Inc. | -487.18 Million USD | 50.294% |
| Nymox Pharmaceutical Corporation | -6.65 Million USD | -3540.439% |
| Third Harmonic Bio, Inc. | -43.95 Million USD | -450.944% |
| ArriVent BioPharma, Inc. Common Stock | -74.59 Million USD | -224.657% |
| AN2 Therapeutics, Inc. | -69.63 Million USD | -247.759% |
| Anixa Biosciences, Inc. | -11.01 Million USD | -2099.273% |
| Vertex Pharmaceuticals Incorporated | 4.3 Billion USD | 105.622% |
| Denali Therapeutics Inc. | -196.69 Million USD | -23.113% |
| Revelation Biosciences, Inc. | -8.65 Million USD | -2697.406% |
| Veru Inc. | -93.78 Million USD | -158.217% |
| Corvus Pharmaceuticals, Inc. | -23.32 Million USD | -938.03% |
| Cingulate Inc. | -22.75 Million USD | -964.019% |
| Passage Bio, Inc. | -108.38 Million USD | -123.419% |
| Context Therapeutics Inc. | -25.07 Million USD | -865.843% |
| Exicure, Inc. | -14.99 Million USD | -1514.844% |
| Day One Biopharmaceuticals, Inc. | -206.06 Million USD | -17.518% |
| Oramed Pharmaceuticals Inc. | -40.59 Million USD | -496.488% |
| Scinai Immunotherapeutics Ltd. | -9.71 Million USD | -2392.164% |
| Rhythm Pharmaceuticals, Inc. | -184.35 Million USD | -31.355% |
| Nuvalent, Inc. | -149.49 Million USD | -61.99% |
| ABVC BioPharma, Inc. | -8.21 Million USD | -2847.261% |
| Carisma Therapeutics, Inc. | -88.73 Million USD | -172.917% |
| Unicycive Therapeutics, Inc. | -20.77 Million USD | -1065.698% |
| OmniAb, Inc. | -69.41 Million USD | -248.841% |
| Anew Medical, Inc. | -1.3 Million USD | -18515.817% |
| Fennec Pharmaceuticals Inc. | -12.77 Million USD | -1796.187% |
| Lipocine Inc. | -17.93 Million USD | -1250.525% |
| Lexeo Therapeutics, Inc. Common Stock | -68.51 Million USD | -253.454% |
| Nautilus Biotechnology, Inc. | -76.15 Million USD | -217.998% |
| SAB Biotherapeutics, Inc. | -38.07 Million USD | -536.008% |
| G1 Therapeutics, Inc. | -39.52 Million USD | -512.65% |
| Bellerophon Therapeutics, Inc. | -22.38 Million USD | -981.853% |
| Sage Therapeutics, Inc. | -579.84 Million USD | 58.237% |
| Ocugen, Inc. | -65.53 Million USD | -269.538% |
| Mind Medicine (MindMed) Inc. | -93.86 Million USD | -157.987% |
| Q32 Bio Inc. | -92.1 Million USD | -162.928% |
| Brainstorm Cell Therapeutics Inc. | -21.43 Million USD | -1029.54% |
| Alumis Inc. Common Stock | -158.17 Million USD | -53.098% |
| Equillium, Inc. | -14.52 Million USD | -1567.553% |
| Kyverna Therapeutics, Inc. | -62.4 Million USD | -288.043% |
| Coya Therapeutics, Inc. | -7.9 Million USD | -2964.043% |
| CNS Pharmaceuticals, Inc. | -18.86 Million USD | -1183.65% |
| Galera Therapeutics, Inc. | -46.95 Million USD | -415.776% |
| Evelo Biosciences, Inc. | -108.46 Million USD | -123.261% |
| Comera Life Sciences Holdings, Inc. | -11.97 Million USD | -1923.072% |
| Dominari Holdings Inc. | -21.79 Million USD | -1011.039% |
| Edesa Biotech, Inc. | -9.22 Million USD | -2525.7% |
| vTv Therapeutics Inc. | -25.5 Million USD | -849.58% |
| Bio-Techne Corporation | 206.68 Million USD | 217.164% |
| Agios Pharmaceuticals, Inc. | -391.48 Million USD | 38.143% |
| Harmony Biosciences Holdings, Inc. | 192.03 Million USD | 226.106% |
| Prelude Therapeutics Incorporated | -132.27 Million USD | -83.072% |
| Candel Therapeutics, Inc. | -38.39 Million USD | -530.778% |
| iTeos Therapeutics, Inc. | -151.1 Million USD | -60.265% |
| Nkarta, Inc. | -131.65 Million USD | -83.944% |
| BioCardia, Inc. | -11.64 Million USD | -1979.715% |
| Iterum Therapeutics plc | -47.46 Million USD | -410.158% |